One institutions' experience with a true standard 15 mCi dose of I-131 for the treatment of Graves' disease.

Muhleman, Mitchel A; Fahim, Ali; Benefield, Thad; Oldan, Jorge D; Khandani, Amir H

Muhleman, Mitchel A; Fahim, Ali; Benefield, Thad; Oldan, Jorge D; Khandani, Amir H.

Afiliação

Muhleman MA; Department of Molecular Imaging and Therapeutics, University of North Carolina School of Medicine.
Fahim A; Department of Neurology, University of North Carolina.
Benefield T; Epidemiology Research Division, University of North Carolina, Chapel Hill, North Carolina, USA.
Oldan JD; Department of Molecular Imaging and Therapeutics, University of North Carolina School of Medicine.
Khandani AH; Department of Molecular Imaging and Therapeutics, University of North Carolina School of Medicine.

Nucl Med Commun ; 44(1): 49-55, 2023 Jan 01.

Article em En | MEDLINE | ID: mdl-36514928

Assuntos

Doença de Graves; Hipertireoidismo; Humanos; Radioisótopos do Iodo/efeitos adversos; Estudos Retrospectivos; Resultado do Tratamento; Doença de Graves/radioterapia; Hipertireoidismo/radioterapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Graves / Hipertireoidismo Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nucl Med Commun Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google